Glargine Insulin Versus Continous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)
Phase of Trial: Phase IV
Latest Information Update: 29 Feb 2016
Price : $35 *
At a glance
- Drugs Insulin glargine (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 24 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Apr 2015 Planned primary completion date changed from 1 Jan 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
- 21 Aug 2014 New trial record